HHS
Harte-Hanks, Inc. Common Stock
stock NASDAQ

I cannot imagine rescheduling not happening although I've never understood why this administration chose to make this a medical/recreational thing.
The next statement comes from the DEA's own website. This rationale is difficult to contest. There are actually facts from the HHS Report embedded in what I consider to be a reasonable assessment:
1. Acceptance of Medical Use in Treatment
* Marijuana no longer meets the Schedule I criteria of having "no currently accepted medical use".
* The federal government recognizes that broad-based data from state programs demonstrates widespread therapeutic use. More than 30,000 practitioners treat upwards of 6 million medical marijuana patients across 43 U.S. jurisdictions, **establishing accepted medical utility for conditions such as anorexia, nausea, and chronic pain.**
2. Reduced Potential for Abuse
* While acknowledging marijuana remains a drug capable of causing harm, its abuse potential is lower than that of Schedule I or Schedule II substances (such as heroin or fentanyl).
* Data indicates that while marijuana is widely consumed, its overall rate of serious adverse health outcomes, high-risk physical addiction, and overdose mortality profile aligns much more consistently with the threshold of Schedule III drugs (which includes substances like ketamine, anabolic steroids, and Tylenol with codeine).
3. Moderate or Low Physical Dependence Risk
* Schedule III requires a drug to carry a low-to-moderate risk of physical dependence or a high risk of psychological dependence.
* Federal medical data concluded that the physical withdrawal and dependence profile associated with chronic cannabis use, while prevalent, does not mirror the severe, physically life-threatening withdrawal symptoms seen in higher-schedule narcotics and depressants.

Sure. The GAO report itself actually underscores that the broader scheduling system functions as intended by the law.
The GAO report explicitly and specifically notes that despite the lack of written internal manuals, the actual scheduling results are consistent. Between 2020 and 2025, the DEA acted on 208 substances. For every single one of the 95 drugs where an HHS evaluation was legally required, the DEA considered it and aligned perfectly with the HHS medical recommendation in every finalized case. Specifically, look at pages 9 and 12-14 of the GAO full report https://www.gao.gov/assets/gao-26-108623.pdf

Yup, I’m here to kick up rocks again. Please remember, I only vote blue & I live in the super blue state. But I do have to point out the real danger and yes, I’m learning the hard way; Democrats don’t believe the B.S they’re peddling.
My original thesis: Democrats will do everything they can to delay or derail the rescheduling process.
Here’s what A.I found;
I dug into the actual GAO report, and **there is a significant connection to Cory Booker**
**What the GAO report itself says**
The report is **GAO-26-108623, released September 23, 2026**. GAO says the work was conducted from **July 2025 through September 2026** and was done because **members of Congress had raised questions about how DEA handles HHS scientific evaluations and scheduling recommendations.**
It’s me again, LandStander420. Now consider Schumer’s bill CAOA. Which seeks to throw away all progress made during rescheduling, start over, fully legalize, but impose at tax 250X higher than cigarettes and 1000sX higher than alcohol.
What is the timeline on that?? How many years would that put on the clock?
Big investors know this, it isn’t stock manipulation. They’re pulling out because the risk is too high. If they’re looking at 10 years before anything happens, they want their money to grow elsewhere. Yes, we will bleed today. We will continue to bleed.
Other questions to ask; How much lobbying money has Schumer’s family made from Alcohol and Tobacco lobbyists?
You can start your downvotes and snarky comments now.

Just so we are all clear, this stay is due to the concern both HHS and DEA allegedly do not have a formalized scheduling process.
If true, then it potentially invalidates every scheduling, inclusive of marijuana being categorized as S1 in the first place.
I doubt the DOJ wants to open that can of worms…but then, I did not think we would see gas at $5 with this “Drill Baby Drill” President.

I cannot imagine rescheduling not happening although I've never understood why this administration chose to make this a medical/recreational thing.
The next statement comes from the DEA's own website. This rationale is difficult to contest. There are actually facts from the HHS Report embedded in what I consider to be a reasonable assessment:
1. Acceptance of Medical Use in Treatment
* Marijuana no longer meets the Schedule I criteria of having "no currently accepted medical use".
* The federal government recognizes that broad-based data from state programs demonstrates widespread therapeutic use. More than 30,000 practitioners treat upwards of 6 million medical marijuana patients across 43 U.S. jurisdictions, **establishing accepted medical utility for conditions such as anorexia, nausea, and chronic pain.**
2. Reduced Potential for Abuse
* While acknowledging marijuana remains a drug capable of causing harm, its abuse potential is lower than that of Schedule I or Schedule II substances (such as heroin or fentanyl).
* Data indicates that while marijuana is widely consumed, its overall rate of serious adverse health outcomes, high-risk physical addiction, and overdose mortality profile aligns much more consistently with the threshold of Schedule III drugs (which includes substances like ketamine, anabolic steroids, and Tylenol with codeine).
3. Moderate or Low Physical Dependence Risk
* Schedule III requires a drug to carry a low-to-moderate risk of physical dependence or a high risk of psychological dependence.
* Federal medical data concluded that the physical withdrawal and dependence profile associated with chronic cannabis use, while prevalent, does not mirror the severe, physically life-threatening withdrawal symptoms seen in higher-schedule narcotics and depressants.

Sure. The GAO report itself actually underscores that the broader scheduling system functions as intended by the law.
The GAO report explicitly and specifically notes that despite the lack of written internal manuals, the actual scheduling results are consistent. Between 2020 and 2025, the DEA acted on 208 substances. For every single one of the 95 drugs where an HHS evaluation was legally required, the DEA considered it and aligned perfectly with the HHS medical recommendation in every finalized case. Specifically, look at pages 9 and 12-14 of the GAO full report https://www.gao.gov/assets/gao-26-108623.pdf

Yup, I’m here to kick up rocks again. Please remember, I only vote blue & I live in the super blue state. But I do have to point out the real danger and yes, I’m learning the hard way; Democrats don’t believe the B.S they’re peddling.
My original thesis: Democrats will do everything they can to delay or derail the rescheduling process.
Here’s what A.I found;
I dug into the actual GAO report, and **there is a significant connection to Cory Booker**
**What the GAO report itself says**
The report is **GAO-26-108623, released September 23, 2026**. GAO says the work was conducted from **July 2025 through September 2026** and was done because **members of Congress had raised questions about how DEA handles HHS scientific evaluations and scheduling recommendations.**
It’s me again, LandStander420. Now consider Schumer’s bill CAOA. Which seeks to throw away all progress made during rescheduling, start over, fully legalize, but impose at tax 250X higher than cigarettes and 1000sX higher than alcohol.
What is the timeline on that?? How many years would that put on the clock?
Big investors know this, it isn’t stock manipulation. They’re pulling out because the risk is too high. If they’re looking at 10 years before anything happens, they want their money to grow elsewhere. Yes, we will bleed today. We will continue to bleed.
Other questions to ask; How much lobbying money has Schumer’s family made from Alcohol and Tobacco lobbyists?
You can start your downvotes and snarky comments now.

Just so we are all clear, this stay is due to the concern both HHS and DEA allegedly do not have a formalized scheduling process.
If true, then it potentially invalidates every scheduling, inclusive of marijuana being categorized as S1 in the first place.
I doubt the DOJ wants to open that can of worms…but then, I did not think we would see gas at $5 with this “Drill Baby Drill” President.

This is based on an AI-assisted review of the new GAO report, Judge Julius’s stay order, and the relevant scheduling procedures. Obviously, this is interpretation, not legal advice.
As has been said before, my takeaway is that the stay may be much more procedural than substantive.
The evidentiary record was essentially complete when the new GAO report came out discussing gaps in DEA/FDA scheduling procedures. Opponents immediately asked to add it to the record and submit supplemental briefing.
Julius could have simply denied the request and moved on. But doing that would leave opponents with an obvious argument for a later appeal: a federal watchdog released a report directly related to the scheduling process, they brought it to the ALJ’s attention before the case was finished, and he refused to meaningfully consider it.
Why give them that argument?
The cleaner approach is to temporarily stay the proceeding, let the government and the other parties respond, and then issue a reasoned decision on whether the GAO report is actually relevant or material to this case.
That does not mean Julius agrees with the opponents’ interpretation of the report. It does not even mean he will admit it into the record. The GAO report itself also needs to be kept in perspective. GAO identified gaps in the formal policies and procedures used by DEA and FDA and recommended that those agencies better document and standardize their processes. It did not conclude that the 2023 HHS marijuana analysis was scientifically wrong, that previous scheduling decisions were invalid, or that marijuana cannot qualify for Schedule III.
And this appears to be a broader institutional issue, not something GAO uncovered specifically about marijuana.
So another reasonable way to read the stay is that Julius is protecting the administrative record before moving forward. If the parties are allowed to address the GAO report now, and Julius later concludes that it does not materially undermine the marijuana analysis, that could actually make the eventual decision harder to attack in court.
What would be much more significant is if Julius concludes that the GAO report exposes a specific defect in the marijuana eight-factor analysis, substantially reopens the evidentiary record, or suggests that the underlying HHS analysis needs to be redone.
For now, the stay itself looks more like an effort to make sure this new issue is properly dealt with and the record is defensible before the case moves forward.
\- Just my AI-assisted two cents

Ok well it was with Trump's DEA longer lol so whatever.
And yet again, Trump's DEA could do NOTHING if Biden's HHS didn't perform the required review. That required actual work.
The absolute refusal to give Biden any credit is absurd when he was the only person to give us anything at all for years.

Biden started this entire Schedule 3 thing lol it's been with Trump's DEA far longer than it was with Biden's DEA.
Trump would have needed to go through the HHS review process if Biden didn't act first. For literally years Biden was the one person to give us real cannabis progress. Idk wtf you are talking about regarding Biden.
Probably completely ignoring Trump's first term too, which gave us the Cole Memo rescinded, hemp loophole pushed through with no Democrat support, zero new research growers approved, etc..

So...what this clearly states is that DEA follows HHS recommendations EVERY - SINGLE - TIME. In other words 100% alignment.
S3 will happen.
What won't happen is S3 opening up recreational selling.
It was never going to do that.
I believe the only thing S3 will do is open up more prescription opportunities as well as facilitate more clinical studies. This might lead to a de-schedule.
Today's double digit declines in some of these MSOs is nonsense. Perhaps there will be a delay, but the evidence for S3 is just overwhelming. This report clearly states just that.

I asked gemini to review and analysis this report and articulate the impact of this report on rescheduling of marijuana and here is what it says..
Summary of Impact
Ultimately, this report does not alter the trajectory of marijuana rescheduling; rather, it solidifies the bureaucratic and legal defensive wall around it. By documenting that the DEA's historical scheduling decisions have aligned perfectly with HHS scientific recommendations (100% alignment for finalized cases from 2020–2025), the GAO structurally reinforces the legitimacy of the DEA following HHS's scientific conclusion that marijuana belongs in Schedule III.

I'm long MSOS, and certainly not selling today...
But sheesh! This sector just can't seem to catch a break. The DEA definition of S3 is:
"A Schedule 3 substance is a drug or chemical with a currently accepted medical use and a moderate-to-low risk of physical dependence, but a potential for moderate-to-high psychological dependence."
Seems like cannabis in this category is a no-brainer. Probably why HHS recommended so very long ago.
One wonders how ketamine and codeine can be considered S3 but cannabis isn't.
The reschedule process stopped making sense long ago, but how difficult must the government make this?
This insanity is absolutely stretching my WTF limits. I didn't think it was possible for this to get more fucked up; yet here we are today.
Just incredible. I mean, truly incredible.

When you have the DEA doing what the HHS has allready done it's bloated unnecessary bureaucracy. DEA enforces laws, not repeat HHS research. This is a flawed re-schedule process that should have ended with the HHS S3 approval.

MORE THAN 3 YEARS SINCE HHS RECCO. Good luck to all the buy the dippers, but here we fucking go again, 3 years later. You think Trump really gives a flying fuck about this? Marihuana Herald, some random dudes blog that makes up rumours and has been wrong multiple times in the last year.

Health and Human Services (HHS) officially recommended reclassifying cannabis to Schedule III on **August 29, 2023.**
**It's been in DEA since.**